9999999997-17-001119.txt : 20170227 9999999997-17-001119.hdr.sgml : 20170227 20170227150056 ACCESSION NUMBER: 9999999997-17-001119 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170227 DATE AS OF CHANGE: 20170227 20170227 20170227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 17641258 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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